Cartilage-hair hypoplasia (CHH) is an autosomal recessive form of metaphyseal chondrodysplasia characterised by short limbed short stature, hypoplastic hair growth, and impaired cell mediated immunity and erythrocyte production.
Patients and methods The material consisted of CHH patients diagnosed and followed at the Department of Medical Genetics or the Children's Hospital, Helsinki University Hospital, which is the major national centre for studying children with growth failure. In addition, a questionnaire study was carried out in 1988 to 1989 in each of Finland's 21 health care districts in order to attain complete ascertainment. The questionnaire was sent to the senior physicians of paediatric, medical genetic, internal medicine, and orthopaedic units of all central hospitals (n = 21) and district hospitals (n = 29) as well as to physicians in charge in health centres (n = 216). The questionnaire consisted of descriptions and illustrations of CHH, diastrophic dysplasia, and achondroplasia, the three most common chondrodysplasias in Finland. Information was requested on any such patients. In case of positive answers, the patients were contacted by their own doctors, and medical records, radiographs, and detailed information on the growth failure were obtained. A clinical study was performed at the Children's Hospital if CHH was suspected. Furthermore, CHH patients were looked for and personally contacted at the meetings of the Association of Little People in Finland.
The diagnosis of CHH was based on short limbed short stature, generalised laxity of joint ligaments and, in childhood radiographs, metaphyseal flaring and irregularities of the growth plates. Hair hypoplasia was used only as a positive criterion; normal hair does not exclude CHH (Makitie and Kaitila, unpublished data). There were seven patients who had normal hair but otherwise typical features of CHH. Two of them had a sib, and another two a relative, all with typical features of CHH.
Since present urbanisation has mixed the possible regional clusters, differences in regional gene frequencies were assessed by the great grandparents' birth places. The patients' and their great grandparents' birth places and the great grandparents' identity were confirmed from the population register. Detailed genealogy was available for some families. For the incidence calculation the number of annual live births was obtained from the Statistical Yearbook.8 Information on abortions was obtained from parents and hospital records and was compared with the abortion frequency in the normal population.9 If the family had not been contacted recently, the number of sibs was verified from the population register. Heights of the sibs were recorded from the child health centres to find possible undiagnosed patients. Segregation analysis was performed with the 'singles method"' and the 'a priori method'," 12 which both assume truncate complete ascertainment, and with the 'sib method'," which assumes single incomplete ascertainment.
The study was approved by the ethical committee of the Children's Hospital.
Results
The epidemiological study showed a total of 107 Finnish CHH patients, 46 males and 61 females, in 85 families. Eighty patients had been followed at the Department of Medical Genetics or the Children's Hospital. Eighteen families with 26 CHH patients were added through the questionnaire study and one patient through the Association of Little People. Eighteen of the 107 patients had died, seven of them under the age of 1 year. The living patients ranged in age from 1 to 51 years, median 21 years. The incidence of CHH calculated for the 10 year period 1977 to 1986 was 1:23 000 live births, which means about three new patients yearly (fig 1) . The frequency of spontaneous abortions was 8%, which is not higher than the abortion frequency in the normal population. There was no apparent relationship between the birth order and occurrence of CHH.
Two female patients from two Finnish families lived in Sweden. Since adequate information on their sibs or ancestors could not be obtained, they were not included in the segregation analysis. Thus, the series consisted of 105 Finnish CHH patients in 83 families ( fig  2) . Fourteen families had two affected sibs and four families had three. Altogether there were 157 unaffected sibs in the families. Using the correction for the 'singles method', the ratio of the affected sibs was 0-203 (SE 0 036). By the 'a priori method' the observed number of patients (105) was lower than expected on the basis of recessive inheritance (111, SE 5-0). The 'sib method' resulted in a ratio of 0-123 (SE 0 025) of the affected sibs.
The patients' and their great grandparents' birth places showed an accumulation in a small area in western Finland, Southern Ostrobothnia. Furthermore, the gene was more frequent in three other areas: the south-eastern corner of the country, Northern Savonia, and the most southern part of Lapland (fig 3) . The incidence in the high frequency area of South- 22 20 a Alive (n = 89) 18 E Dead (n= 18) em Ostrobothnia was 1:3000 live births. Consanguinity, not closer than third cousins, was found within two families, and interfamilial relationships in 20 families (fig 4) . In more cases, however, possible remote relationships between the families could not be detected, since the ancestors were not traced back further than the great grandparents. Six female patients were married to unaffected males. Two of these couples had two children and two had one child. All the children had been delivered by caesarean section and were healthy. None of the male patients was married or had children. some 30 rare autosomal recessive disorders and lack of some others, is the result of national and regional isolation of the small population.3435 Most of the ancestors of CHH families originated from a small area in western Finland with some regional clusters in a few eastern and south-eastern communities. These are sparsely inhabited rural areas which were permanently settled as late as the sixteenth century and are still isolated.35 Even today most native inhabitants of these communities are descendants of a few settlers from 15 to 20 generations back and are therefore remotely related to one another.3536 The break up of isolates by increasing migration to towns will in the future slowly even out the clustering of recessive genes and thereby result in a decrease in the incidence of CHH. The patients' birth places, however, still gave evidence of accumulations similar to their great grandparents' birth places. Calculated using the Hardy-Weinberg coefficient, the gene frequency for the whole country was 0-0066 and for the high frequency area of Southern Ostrobothnia 0-018, and the carrier frequencies were 1:76 and 1:29, respectively. However, this method is partly invalidated by uneven distribution of the gene in the Finnish population. The present study showed consanguinity in two families and interfamilial relationships in 20 families. However, by tracing the ancestors back further than the great grandparents, several other remote relationships within and between CHH families would certainly have emerged.
In the study of CHH among the Amish, the number of affected was higher for females than for males (46 v 31).2 Similarly, females were overrepresented among the Finnish patients (61 v 46). When the two groups are combined, the sex ratio is 1:1 4 (X2=2214, NS).
Autosomal recessive inheritance was established in a study of CHH in 53 Amish sibships. However, as the number of affected patients was significantly lower than expected on the basis of the recessive hypothesis (72 v 98-5, SE 6 8), reduced penetrance of about 70% was suggested.2 The other possible explanations discussed were contamination of the series by numerous sporadic, mimicking dominant conditions, non-random chromosome segregation, gametic selection, and increased mortality in utero.2 The segregation analysis of 83 Finnish CHH families was performed by methods of complete and incomplete ascertainment. The ascertainment was probably close to complete among young patients, but incomplete in the older age groups, since no patients over 51 years of age were ascertained. As the ascertainment was somewhere between complete and incomplete, the corrected ratio of affected patients lies between those derived by the two extreme methods, that is, between 0-203 (SE 0 036) and 0-123 (SE 0025). The result is in accordance with reduced penetrance. Five more patients in these families would have resulted in a ratio of 0-25 ('singles method'). The abortion frequency among the Finnish CHH families does not support increased mortality in utero. The lack of affected patients is too great to be explained 
